Could a growth hormone help people with End-Stage liver disease?
NCT ID NCT05253287
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether giving growth hormone to people with decompensated liver cirrhosis (advanced liver scarring) could improve their health and survival. The trial included 96 adults with this condition. Researchers measured how long patients survived without major complications or needing a liver transplant, and checked for side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIGESTIVE SYSTEM DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Postgraduate Institute of Medical education and Research
Chandigarh, Uttarakhand, 160012, India
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- Could muscle loss predict stroke recovery?
- Can nerve changes explain Age-Related muscle loss?
- Muscle loss in aging: can diet and exercise turn back the clock?
- A tiny dose of an old drug might stop Post-Surgery brain fog in seniors
- Could a simple CT scan reveal which ICU cancer patients are at highest risk?